Fmoc-4-Iodo-D-Phenylalanine

Fmoc-4-Iodo-D-Phenylalanine is a D-configured phenylalanine derivative bearing an ortho-iodination at the aromatic ring (4-iodo relative to the side-chain) and an N-(9H-fluoren-9-ylmethoxycarbonyl) (Fmoc) protecting group on the amino functionality. The molecule contains a chiral α-carbon, a protected amine suitable for base-stable peptide chemistry, and a reactive aryl iodide that can participate in cross-coupling and electrophilic aromatic substitution strategies. The Fmoc carbamate enables standard solid-phase or solution-phase peptide assembly workflows by allowing orthogonal deprotection under mild basic conditions, while the aryl iodide provides a handle for late-stage diversification. The combination of stereodefined amino acid architecture and a functionalizable iodoaryl side chain makes the compound a practical chiral intermediate for peptide building block preparation and subsequent synthetic elaboration.

1. Peptide Synthesis

Fmoc-4-Iodo-D-Phenylalanine is used in peptide synthesis workflows where a protected, stereodefined amino acid building block is required for controlled chain assembly. The Fmoc-protected amine supports peptide coupling chemistry at the N-terminus, while the D-stereocenter governs the stereochemical outcome of the resulting peptide backbone. The aryl iodide side chain can be retained through coupling steps and then leveraged for post-assembly functionalization, enabling iodine-to-heteroaryl or iodine-to-alkyl transformations on the peptide or peptidomimetic scaffold. Downstream, the iodinated residue can be used to generate analog series for structure-activity relationship studies and to prepare radiolabeling-ready or cross-coupling-ready peptide derivatives.

2. Chiral Synthesis

Fmoc-4-Iodo-D-Phenylalanine functions as a chiral amino acid intermediate for stereoselective synthesis of enantiomerically defined aromatic amino acid derivatives. The D-configuration at the α-carbon provides a predictable stereochemical element for downstream transformations, including conversion into other protected or activated amino acid forms. The Fmoc carbamate offers a stable protecting-group strategy during intermediate handling, while the aryl iodide provides a chemically reactive site that can be exchanged for other aryl substituents via palladium-catalyzed coupling or related methods. The resulting diversified chiral aromatic amino acid products can serve as inputs for medicinal chemistry libraries, peptidomimetic construction, and fine chemical synthesis routes requiring stereochemical fidelity.

3. Side-Chain Functionalization

Fmoc-4-Iodo-D-Phenylalanine is applied in side-chain functionalization strategies that exploit the aryl iodide as a late-stage diversification handle. The protected amino group and Fmoc group allow orthogonal manipulation of the aromatic substituent without disturbing peptide-ready functionality, supporting sequential synthetic planning from amino acid ester or peptide building block stages. The iodoaryl moiety can undergo cross-coupling to install substituted phenyl, heteroaryl, or conjugation-ready motifs, enabling systematic modification of aromatic electronics and steric profile. The modified derivatives can then be incorporated into peptides or used as standalone aromatic amino acid analogs for biochemical research intermediate preparation and molecular scaffold tuning.

4. Bioconjugation Chemistry

Fmoc-4-Iodo-D-Phenylalanine is suitable for bioconjugation and chemical biology workflows where an amino acid-derived residue is used to introduce a defined reactive aromatic handle into biomolecule scaffolds. The Fmoc-protected amine supports controlled incorporation into peptide tags or linker peptides, while the D-configuration can be used to tune protease resistance and stereochemical recognition in peptide-based conjugates. The aryl iodide can serve as a functional group for subsequent coupling to introduce affinity tags, fluorophores, or bioorthogonal fragments through established coupling chemistries compatible with complex molecule assembly. The resulting labeled or modified peptide conjugates can function as tools for biomolecule labeling, protein interaction mapping, and reagent generation for analytical research.

5. Pharmaceutical Manufacturing

Fmoc-4-Iodo-D-Phenylalanine is employed in pharmaceutical manufacturing-oriented peptide intermediate preparation where protected amino acid building blocks are processed under controlled synthetic conditions. The Fmoc carbamate provides a robust N-protection strategy that can be removed cleanly in peptide manufacturing cycles, enabling reproducible N-terminal formation during stepwise assembly. The aryl iodide enables controlled diversification of aromatic side chains in downstream manufacturing steps, supporting the generation of peptide analogs and impurity-controlled intermediates by defining a single, well-characterized functional handle. The stereodefined D-phenylalanine architecture supports consistent specification of stereochemical content in peptide drug substance or peptide-like intermediate syntheses, aligning with industrial requirements for defined structural motifs.

1. High fat diet and GLP-1 drugs induce pancreatic injury in mice

2. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats